Skip to search formSkip to main contentSkip to account menu

nexopamil

National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

LU 49938

Broader (1)

Verapamil
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
Potent antifibrillatory effect of combined blockade of calcium channels and 5-HT2 receptors with nexopamil during myocardial ischemia and reperfusion in dogs: comparison to diltiazem.
The need for novel antifibrillatory therapy is underscored by clinical trials indicating that the incidence of sudden cardiac… 
1995
1995
The effect of LU‐49938 (nexopamil) on the activation by serotonin of mesangial cells
Summary— Intraglomerular platelet activation may release vasoactive agents such as serotonin (5‐hydroxytryptamine, 5‐HT) that may… 
1994
1994
Protection of Reperfused Ischemic Pig Myocardium by Nexopamil, a New Combined Ca2+ and Serotonin Antagonist
We investigated the ability of a newly developed calcium and serotonin (5-HT2) antagonist, nexopamil, to protect the heart from… 
1994
1994
Nexopamil (LU 49938), A Combined Ca2+ Channel Blocker and 5HT2 Receptor Antagonist
1993
1993
Inhibition by the Combined Ca2+ and 5‐HT2 Receptor Antagonist Nexopamil (LU 49938) of Intracoronary Thrombus Formation in a Canine Model of Arterial Stenosis and Intimal Damage
We investigated the effects of nexopamil, a combined Ca2+/5-HT2 antagonist on thrombus formation in vivo and on platelet… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)